When: 23 to 26 March, 2026
Where: New York, New York
Susan Lynch-Smith, Head of Business Development, will be representing Douglas CDMO at DCAT Week 2026 in New York City. As the premier global event for the bio/pharmaceutical manufacturing value chain, DCAT is the ideal platform to discuss how our fully integrated New Zealand facility can accelerate your drug development and commercialization timelines.
With over 30 years of experience in high-potency small molecule formulation, Douglas provides the technical depth required for the industry’s most challenging projects. Susan is available to discuss how our specialized capabilities can support your next innovation, including:
-
Advanced softgel encapsulation: Leveraging our position as a global leader in softgel capsule development to enhance the bioavailability of poorly soluble compounds.
-
HPAPI manufacturing: High-containment solutions for handling potent actives, including cytotoxics, hormones, and immunosuppressants.
-
Therapeutic specialization: End-to-end support for prescription drugs in oncology, dermatology, the central nervous system (CNS), and endocrinology.
-
The New Zealand advantage: Learn how our streamlined regulatory processes and R&D incentives can shorten your path to clinical trials and market entry.
Schedule a Meeting in NYC
Whether you are managing a complex generic or an innovative specialty drug, Douglas CDMO offers the agility and expertise to move your molecule from concept to commercial supply.
Connect with Susan Lynch-Smith: If you would like to schedule a 1-on-1 meeting during DCAT Week to explore strategic collaboration or outsourcing opportunities, please reach out via the contact details below.
Connect with Susan
Get in touch
Contact usOther posts you may be interested in...
Articles
Bespoke client solutions: A personalized approach as a privately owned CDMO
Douglas CDMO is making its mark in the pharmaceutical development industry with their flexible and personalized approaches to client needs.
Learn MoreCase Studies
Providing packing and blinding solutions for an innovative botanical drug start-up
Douglas CDMO provided their existing GMP infrastructure to support a client’s packing and labeling needs for investigational medicinal products in blinded clinical studies.
Learn MoreArticles
Smart softgels: driving innovation in pharma
In the dynamic landscape of pharmaceuticals, one innovation has consistently pushed the boundaries of drug delivery: the softgel capsule.
Learn More